Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Ḧurthle-cell neoplasms of the thyroid

American Journal of Surgery

Volumn 200, Issue 1, 2010, Pages 41-46

  Suh, Insoo ^a   Vriens, Menno R ^a   Guerrero, Marlon A ^a   Griffin, Ann ^b   Shen, Wen T ^a   Duh, Quan Yang ^a   Clark, Orlo H ^a   Kebebew, Electron ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biological markers; Follicular thyroid neoplasms; H rthle cell thyroid neoplasms; Thyroglobulin; Thyroid nodules

Indexed keywords

BIOLOGICAL MARKER; THYROGLOBULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPHOCYTIC THYROIDITIS; MALE; MEDICAL RECORD REVIEW; NODULAR GOITER; NODULAR HYPERPLASIA; ONCOCYTOMA; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA, FOLLICULAR; ADENOMA, OXYPHILIC; ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 77955461906     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.08.030     Document Type: Article

References (23)

1. H. Gharib, and J.R. Goellner Fine-needle aspiration biopsy of the thyroid: an appraisal Ann Intern Med 118 1993 282 289
2. M.R. Castro, and H. Gharib Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls Endocr Pract 9 2003 128 136
3. C. Ravetto, L. Colombo, and M.E. Dottorini Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients Cancer 90 2000 357 363
4. A.A. Renshaw Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves Am J Clin Pathol 116 2001 477 482
5. C.F. Eustatia-Rutten, J.W. Smit, and J.A. Romijn, et al. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis Clin Endocrinol (Oxf) 61 2004 61 74
6. L. Giovanella Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management Clin Chem Lab Med 46 2008 1067 1073
7. M. Gupta, and S.Y. Chia Circulating thyroid cancer markers Curr Opin Endocrinol Diabetes Obes 14 2007 383 388
8. R.T. Kloos, and E.L. Mazzaferri A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later J Clin Endocrinol Metab 90 2005 5047 5057
9. S. Leboulleux, C. Rubino, and E. Baudin, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis J Clin Endocrinol Metab 90 2005 5723 5729
10. R.J. Whitley, and K.B. Ain Thyroglobulin: a specific serum marker for the management of thyroid carcinoma Clin Lab Med 24 2004 29 47
11. S.B. Christensen, L. Bondeson, and U.B. Ericsson, et al. Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin A prospective study of 100 surgically treated patients Acta Chir Scand 150 1984 433 439
12. N. Besic, M. Sesek, and B. Peric, et al. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid Med Sci Monit 14 2008 CR459 CR467
13. J. Hrafnkelsson, H. Tulinius, and M. Kjeld, et al. Serum thyroglobulin as a risk factor for thyroid carcinoma Acta Oncol 39 2000 973 977
14. N. Panza, G. Lombardi, and M. De Rosa, et al. High serum thyroglobulin levels Diagnostic indicators in patients with metastases from unknown primary sites Cancer 60 1987 2233 2236
15. J.D. Lin Thyroglobulin and human thyroid cancer Clin Chim Acta 388 2008 15 21
16. A.K. Sharma, A.K. Sarda, and T.K. Chattopadhyay, et al. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers J Postgrad Med 42 1996 39 42
17. M. Schlumberger, A. Hitzel, and M.E. Toubert, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients J Clin Endocrinol Metab 92 2007 2487 2495
18. E.L. Mazzaferri, and R.T. Kloos Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions Thyroid 10 2000 767 778
19. P.R. Maddox, and M.H. Wheeler Approach to thyroid nodules O.H. Clark, Q.Y. Duh, E. Kebebew, eds. Textbook of Endocrine Surgery 2nd ed. 2005 Elsevier Saunders Philadelphia 85 92
20. T. Okamoto, M. Kanbe, and M. Iihara, et al. Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications Endocr J 44 1997 187 193
21. Z.W. Baloch, S. Hendreen, and P.K. Gupta, et al. Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules Diagn Cytopathol 25 2001 231 234
22. Y.Y. Tan, E. Kebebew, and E. Reiff, et al. Does routine consultation of thyroid fine-needle aspiration cytology change surgical management? J Am Coll Surg 205 2007 8 12
23. E.G. Lever, S. Refetoff, and N.H. Scherberg, et al. The influence of percutaneous fine needle aspiration on serum thyroglobulin J Clin Endocrinol Metab 56 1983 26 29